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Abstract
BACKGROUND: Sentinel lymph node (SNL) biopsy in breast cancer for the determination of axillary status is 
standard procedures in surgical treatment of early-stage breast cancer. The identification of the SNL is usually 
performed by radiocolloid injection or/and injection of methylene blue due. The use of indocyanine green (ICG) dye, 
which is fluorescent dye, which movement in breast and axillar pit, can be followed with special cameras which detect 
near infrared specatar of light. 
CASE REPORT: In this paper, we present case report of patient with breast cancer, where we perform SNL detection 
with three methods: Use of radiocolloid which we trace with static gamma camera, and intraoperatively with hand held 
gamma probe, methylene blue dye which movement we followed by eye contact and using indocyanine green which 
movement was followed by specially constructed multispectral camera, which can detect near-infrared fluorescence 
that is emitted by ICG and methyline blue, respectively. 
CONCLUSION: Fluorescent imaging with ICG is a sensitive, valuable, and safe method for SNL biopsy. Finding 
new agents that would identify the SNL, especially if they are not radioactive would be an important step in wider 
application of this method.
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Introduction
The identification and biopsy of sentinel 
lymph node (SNL) in breast cancer for determination 
of axillary status and stage of the disease are already 
standard procedures in treatment of early-stage breast 
cancer [1], [2], [3].
The identification of the SNL is usually 
performed by radiocolloid injection that is further traced 
with a static gamma camera, i.e., intraoperatively with 
a hand-held gamma detector probe, as well as by 
injection of methylene blue.
Finding new agents that would identify the 
SNL, especially if they are not radioactive would be an 
important step in wider application of this method.
Case Report
In a 48-year-old patient with a malignant 
tumor in the upper-lateral quadrant of the left breast 
13 mm × 12 mm in size, with clinically node negative 
axilla, SNL was to be identified. This patient was 
involved in the clinical trial approved by the Institutional 
Review Board of the University of Illinois at Urbana-
Champaign (IRB #18947) and by the Agency for 
Drugs and Medical Instruments in Skopje, Republic of 
Macedonia (11-7442/3). The study complied with all 
ethical regulations. The study was registered on the 
website: clinicaltrials.gov (trial ID no. NCT03619967).
Four hours before surgery, a radionuclide 
mTc99-SENTI-SCINT (MEDI-RADIOPHARMA LTD. 
Hungary; human serum albumin nano sized colloid; 
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100–600 nm) at a dose of 4 mC (150 MBq) was injected 
at four points periareolar subcutaneously. Images with 
static gamma camera were made at 0 time, 60 min after 
application, and 90 min after application (Figure 1).
Figure 1: Static scan preoperatively 90 min after application
After detection of SNL with the static gamma 
camera, mapping of the SNL with radioactive tracer 
followed. At the same time, preoperatively, single-photon 
emission computed tomography scan was made that 
visualized the SNL and its relation with the surrounding 
structures (Figures 2 and 3).
Figure 2: Single-photon emission computed tomography scan 
preoperatively
After mapping the SNL, the patient underwent 
a surgery under general anesthesia. This was followed 
by injection of 20 ml 0.05% sterile solution of methylene 
blue at low-medial breast site in the direction towards the
Figure 3: Single-photon emission computed tomography scan 
preoperatively  
axilla. After application of methylene blue, periareolar 
injection of 2 ml (5 mg) indocyanine green (ICG) (ICG 
for injection, USP (Patheon Italia S.p.A.) at four sites 
followed. The breast was massaged for 10 min to 
distribute the dye toward the axillary lymph nodes. Both 
ICG and methylene blue were imaged around 30 min 
post-administration with a custom fluorescent camera.
Cleaning/cleansing of the surgical field and 
isolation was the next steps.
A small incision in the axilla 1–2 cm was made 
on a previously defined site for the identification of the 
SNL.
Tracing of the injected radiocolloid and dyes as 
well as identification of the SNL intraoperatively were 
performed with:
•	 Hand-held gamma detector probe 
EUROPROBE SYSTEM CE 0459
•	 Standard color camera
•	 Multispectral camera, which can detect near-
infrared fluorescence (NIR) that is emitted 
by ICG and methyline blue, respectively. The 
SLN mapping and resection were imaged with 
our bio-inspired sensor under simultaneous 
surgical light illumination (60 kLux) and two 
laser light excitations with 10 mW∕cm2 intensity 
at 780 nm and 665 nm. The imaging and 
illumination systems were set up at a 1-m 
working distance. The image sensor was 
equipped with a Canon EF 50mm f/1.2 lens that 
was focused on the patient and adjusted to an 
aperture of f/2.2. The sensor was configured to 
provide a 0.1-ms exposure to the color pixels to 
ensure non-saturated color images, and 33-ms 
exposure to the NIR pixels to ensure high SNR 
fluorescence signals and imaging rates of 30 
FPS. ICG and MB fluorescence from resected 
lymph nodes was compared against visual 
detection and radioactive activity (Figure 4)
•	 Macroscopic visualization of blue-colored 
tissues and lymph nodes.
Lymph nodes with blue coloration and 
radioactivity were excised and sent in frozen sections 
for histological analysis. The wound site was imaged 
with a custom bio-inspired camera capable of detecting 
fluorescence from ICG and MB. No clinical decision was 
made based on the fluorescence data because of the 
IRB protocol. The resected samples were compared for 
fluorescence, visual coloration, and radioactive activity.
After resection of the lesions, the axillary basin 
was locally examined for present radioactivity and 
coloration.
Three nodes with surrounding fat tissue were 
excised based on coloration and radioactive activity. A total 
of six nodes were detected in our patients. All of them were 
confirmed to be node negative (no metastatic deposits) on 
frozen sections as well as on paraffin sections.
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While waiting for the biopsy result (e.g., tempore 
analysis), a surgical procedure was undertaken for 
breast cancer treatment. Quadrantectomy of the upper-
lateral quadrant of the left breast was performed where 
the tumor was located. As soon as, the result from the 
axillary lymph nodes was obtained revealing that there 
were no metastatic deposits, the surgical wound was 
closed in layers.
It was confirmed in this patient that blue-
dye colored lymph nodes were also hot (filled with 
radioactivity), which was detected with a hand-held 
gamma detector probe, but they were also fluorescent 
(fluorescent-colored) detected with a multispectral 
camera. In fact, it was confirmed that ICG dye is suitable 
for identification/mapping of SNL in the armpit.
Discussion
The procedure for the identification of SNLs 
was described for the 1st time in a parathyroid gland 
cancer study by Gould in 1960. Years later, in 1977 
Cabanas presented evidence of the existence of 
SNLs in penile carcinoma. The Cabanas’ hypothesis 
was that the diffusion of malignant cells in lymphatic 
organs follows an orderly, predictable pattern: It first 
affects one node, which he named the sentinel node, 
and then it is spread to the remaining lymph nodes 
of the drainage basin. By detecting and histological 
examination the SNL, the condition of the other lymph 
nodes of that basin can be predicted. This method was 
used for the first time for the clinical detection of breast 
cancer in 1992 by Krag, who had used radioactive 
technetium sulfur colloid for the mapping of the SNLs. 
Using this method, the SNL was detected in 83% of 
the cases. In 1994, for the 1st time Armando Giuliano 
declared this method to be safe in the determination 
of axillary lymph node status and he used isosulfan 
vital blue dye to identify SNL in 89% of the cases. This 
procedure was later also used by Umberto Veronesi. 
Albertini used both of these methods and increased 
the identification rate to 92% [4], [5]. In 2005, Veronesi 
published his long-term initial results in the detection 
of SNLs; he presented the benefits of this method and 
in 2006 he suggested it for the determination of the 
disease stage [1], [2], [3].
Today, metadata for the detection and the 
biopsy of SNLs is a standard method in all protocols 
for the treatment of armpit in early-stage breast cancer 
with clinically negative axillary lymph nodes (there 
are no enlarged lymph nodes in the armpit clinically 
detected). If histological examination shows that the 
SNLs are not affected with metastatic deposit, then 
axillary lymphadenectomy is not performed, but in 
cases of metastatic deposits axillary lymphadenectomy 
have to be realized.
The need for performing metadata for the 
detection and the biopsy of SNLs is a result of the 
following facts:
•	 Recognition of the breast cancer biology helps 
in understanding that axillary lymphadenectomy 
has its role in the disease stage rather than in 
the therapeutic purposes
•	 In 40–60% of patients (depending on active 
mammography screening), there are no 
metastatic deposits in the armpit
•	 In cases of clinically negative armpit (enlarged 
lymph nodes in the armpit are not clinically 
detected), no metastatic changes are detected 
in 70% of those cases and no axillary 
lymphadenectomy is made.
Today, for the detection of the SNLs it is 
standard procedure to use radioisotope mTc99-SENTI-
SCINT (MEDI-RADIOPHARMA LTD. Hungary; human 
serum albumin nano sized colloid; 100–600 nm) at a 
dose of 4 mCi (150 MBq), divided into four separate 
doses (each dose at 1 mCi/37 MBq), applied at four 
sites periareolar subcutaneously, and isosulfan vital 
blue dye or methylene blue at our clinic.
Using this approach, the SNLs are detected 
in 98% of the cases. In conditions where after the 
radiocolloid injection the static scans performed before 
surgery prove the existence of the SNL, the accuracy 
reaches 100%.
Radioisotope usage is related to radioactive 
radiation, requires licensing, has regulatory issues 
around handling and disposal of waste, necessary for 
the Institute for Nuclear Medicine, and may be logistically 
unavailable or difficult to implement in some centers or 
developing-countries. This has led to the development 
of alternative methods such as superparamagnetic iron 
oxide, fluorescence techniques using ICG or fluorescein, 
computed tomography lymphography, and contrast-
enhanced ultrasound scans using microbubbles. 
The newest techniques will potentially enable a more 
widespread adoption of this procedure; however, a 
common barrier for these techniques is the lack of 
standardization and no randomization of trials to evaluate 
their effectiveness against the current standard of care [6].
ICG dye is comprised small molecules of a 
fluorescent dye that can be detected with multispectral 
cameras that can detect light in the near-infrared 
spectrum. ICG is a cyanine dye used in medical 
diagnostics. It is used for determining cardiac output, 
hepatic function, liver and gastric blood flow, perfusion of 
lung, detecting SNLs, and for ophthalmic angiography. 
ICG binds tightly to plasma proteins and becomes 
confined to the vascular system. ICG has a half-life of 
150–180 s and is removed from circulation exclusively 
by the liver to bile juice. The advantages of using this 
dye in the detection of SNLs are its non-toxic feature; 
it is applied locally at minimum doses; it moves quickly, 
and it is presented in the nodes/SNLs in an excellent 
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manner. The frequencies of side effects were only 
0.2%. The camera can display movement of the dye 
under healthy skin without dying the tissue visibly. Due 
to its molecule’s small size, it can quickly pass through 
the SNLs and present itself in the upper nodes too.
Guo et al. in their study comprising 68 patients 
proved that ICG was superior to blue dye for SNL 
identification. Using a photodynamic dye, movement of 
the dye through the lymphatic route could be observed 
in vivo. None of the patients experienced adverse 
effects associated with local application [6].
In 2016, Aydogan et al. presented their initial 
results of SNL biopsy under ICG guidance in four 
patients. They emphasized that ICG is a non-toxic 
substance, invisible under white light, has a short life-
time, but it is perfectly visible in the infrared spectrum 
that can be visualized with a multispectral camera. The 
disadvantage of this method is in the need of a near-
infrared camera that can capture fluorescence up to 
a depth of 21 mm from the skin surface. Furthermore, 
another limitation is the unfavorable influence of 
visualization by surgical lamps, and hence, very often 
it is necessary to use filters for the lamps or to use 
specially designed lamps with defined light spectrum [7].
Vidal-Sicart et al. in a study from 2013 
discusses the identification of SNL indicating the 
use of a radiotracer and a vital blue dye as standard 
techniques. However, he has also pointed out ICG as 
a new fluorescence dye tracer that can be detected 
with specially designed cameras, which detect the 
near-infrared spectrum of beams. The added benefit 
would be the combined application of radiocolloid and 
a fluorescence dye as an integrated tracer that may be 
seen with two techniques for monitoring [8].
Takemoto et al. obtained better results in the 
detection of SNLs if ICG was combined with indigo 
carmine blue than if ICG was applied alone [9].
Pitsinis et al. have presented the advantages 
of using ICG in SNL detection compared to the injection 
of vital blue dye alone. They applied ICG in 50 patients 
and showed a detection rate of 100% in comparison 
with vital blue dye where it reached 96%. To use ICG it is 
necessary to have a photodynamic eye, which registers 
fluorescence in near-infrared spectrum. These results 
are similar to those presented in the literature, where 
the accuracy of ICG in SNL detection is 99–100% 
while for vital blue is 83–93%. The added benefits of 
using ICG are in the fact that it gives almost no allergic 
reactions and does not visibly dye the tissue [10].
Zhang et al., in 2016, performed a meta-analysis 
to investigate the advantages of using ICG in the detection 
of SNLs. They performed a systematic literature search 
and found 67 published studies including 2595 patients. 
The selected studies conformed to all the criteria of 
randomization, additionally lymphadenectomies were 
made in only six studies after SNL identification. After 
analyzing and comparing these studies, an ICG method 
was found viable in the detection of SNLs. Furthermore, 
currently radiocolloid and vital blue dye are considered 
as standard methods of care in the detection of SNL. 
Figure 4: Comparison of the finding presented with color camera and 
multispectral camera after application of indocyanine green
Conclusion
The authors confirm ICG in the detection of 
SNL to have an accuracy of 98% with high sensitivity 
and specificity. Having in mind that isotopes are 
not used, the benefits of this method are even more 
important [11].
Our case report along with the studies from the 
literature lead to the conclusion that usage of ICG in 
the identification of SNLs is a method that is useful to 
be applied in practice, especially having in mind that 
it yields a high detection rate, high sensitivity, high 
specificity, has no adverse effects, and no radioactivity.
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